Romine, P. E., Peterson, L. M., Kurland, B. F., Byrd, D. W., Novakova-Jiresova, A., Muzi, M., . . . Linden, H. M. (2021). 18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study. Breast Cancer Research, 23(1), 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Romine, Perrin E., et al. "18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to Assess Early Response to Aromatase Inhibitors (AI) in Women with ER+ Operable Breast Cancer in a Window-of-opportunity Study."
Breast Cancer Research 23, no. 1 (2021): 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Romine, Perrin E., et al. "18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to Assess Early Response to Aromatase Inhibitors (AI) in Women with ER+ Operable Breast Cancer in a Window-of-opportunity Study."
Breast Cancer Research, vol. 23, no. 1, 2021, pp. 1-12.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.